Adaptimmune Therapeutics Plc
ADAP:NASDAQ
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.
Streetwise Company Fact Sheet2024/4/26 4:46:25
(ADAP:NASDAQ)
Streetwise Reports Articles
| 10/31/2022 - View Article |
| 09/06/2022 - View Article |
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
